extranodal non-Hodgkin lymphoma diagnosis and treatment
Related entities
Findings (27)
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6
None
declineSurvivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6